Notably, several investigations using tetracycline-inducible HIF-2α overexpression models targeting the tubuloepithelial cells in chronic kidney disease and renal warm ischaemia have demonstrated its potential to attenuate renal fibrosis and enhance renal function (43, 45, 46). This evidence concerns the gene EPAS1 and renal fibrosis.